Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report A technical deep-dive into PLA, PHA, and PBS bio-based polymers: synthesis pathways, mechanical performance, application domains, and 2026 innovation trends from 60+ peer-reviewed sources.
Article | Report Beyond teduglutide: how glepaglutide, apraglutide, GLP-2 peptibodies and dual GLP-1/GLP-2 agonists are reshaping the SBS drug pipeline. Patent and clinical signals analysed.
Article | Report How bilateral teleoperation with haptic feedback reduces task completion time in remote surgical robotics — evidence from 50+ patents and studies.
Article | Report Layered oxides, Prussian blue analogs, and NASICON phosphates compared across energy density, cycle life, cost, and air stability for SIB commercialization.
Article | Report Capsule FMT achieves 80% efficacy in rCDI. Explore the drug pipeline: lyophilized cFMT, defined microbial consortia, engraftment biology, and regulatory signals.
Article | Report Explore the 2026 sodium sulfur battery technology landscape: RT-NaS breakthroughs, solid-state electrolytes, key patents, and strategic implications for grid storage.
Article | Report How soft tissue artifact corrupts exoskeleton torque estimation during gait—and 7 proven engineering strategies to reduce error, from ESO to iterative learning control.
Article | Report A 2026 landscape of refractory high-entropy alloys (RHEAs) for aerospace and nuclear applications — covering mechanical performance, oxidation resistance, radiation tolerance, and additive manufacturing advances.
Article | Report Motilin receptor agonists, ghrelin mimetics, 5-HT4 agonists, and GLP-1 modulation: a patent and literature analysis of the gastroparesis drug pipeline.
Article | Report How multibody dynamics simulation of flexible robot links improves trajectory tracking accuracy in high-speed pick-and-place systems. Expert analysis of models, tools & patents.
Article | Report SDH mutation targeting, VEGFR inhibition, and radioligand therapy in the PPGL drug pipeline. Clinical evidence, emerging targets, and strategic implications.
Article | Report How to cut acoustic noise from switched reluctance motors in EV auxiliary pump applications without torque ripple penalty—covering control, PWM, and structural design.
Article | Report Lead-based vs. lead-free perovskite solar cell absorbers in 2026: PCE benchmarks, tin oxidation challenges, encapsulation innovation, and the commercialisation outlook.
Article | Report How to cut acoustic noise from switched reluctance motors in EV auxiliary pump drives without torque ripple penalty—covering current shaping, PWM modulation, and structural design.
Article | Report SDH mutation targeting, VEGFR inhibition, and radioligand therapy in the PPGL drug pipeline. Phase II data, emerging targets, and strategic implications.